Atrial fibrillation in the patients with obesity and arterial hypertension
https://doi.org/10.20514/2226-6704-2015-0-5-62-64
Abstract
About the Authors
N. S. TsyplenkovaRussian Federation
Nizhny Novgorod
E. I. Panova
Russian Federation
Nizhny Novgorod
N. V. Zhdankina
Russian Federation
Nizhny Novgorod
E. P. Morozova
Russian Federation
Nizhny Novgorod
O. V. Karataeva
Russian Federation
Nizhny Novgorod
References
1. Diagnostic and management of atrial fibrillation. Guidelines RSC, RSSA and АCS. Moscow. 2012; 100 p.
2. Sidorova N.V., Solov´yanova E.N., Nosov V.P., Furmenkova Y.V., Malysheva E.B. Daily blood pressure monitoring in clinical practice. Nizhny Novgorod. 2000; 34 p.
3. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society). Circulation. 2005; 112: e154-e235.
4. Feinberg WM, Cornell ES, Nightingale SD, et al. For the Stroke Prevention in Atrial Fibrillation Investigators. Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation. Stroke. 1997; 28: 1101−6.
5. Fuster V. et al. ACC/AHA/ESC Guidelines for the Management of Patients with Atrial Fibrillation. J. Am. Coll. Cardiol. 2001; 38: 1266i−1xx.
6. Kopecky SL, Gersh BJ, McGoon MD, et al. The natural history of lone atrial fibrillation: a population-based study over three decades. N. Engl. J. Med. 1987; 317. Р 669−674.
7. Narkiewicz K. Obesity and hypertension – the issue is more complex than we thought. Nephrol. Dial. Transplant. 2006; Vol. 21(2). P. 264-267.
8. Prystowsky EN, Katz AM. Atrial fibrillation. Textbook of Cardiovascular Medicine. Philadelphia: Lippincott-Raven. 1998: 1827−61.
9. Thomas F., Bean K., Pannier B. et al. Cardiovascular mortality in overweight subjects. The key role of associated risk factors. Hypertension. 2005; Vol. 46. P. 654-663.
10. Unger R.H. Lipotoxic diseases. Annu. Rev. Med. 2002; Vol. 53. P. 319-336.
11. Unger R.H., Scherer P.E. Gluttony, sloth and metabolic syndrome: a roadmap to lipotoxisity. Тrends Endocrinol. Metab. 2010; Vol. 21, №6. P. 345-352.
Review
For citations:
Tsyplenkova N.S., Panova E.I., Zhdankina N.V., Morozova E.P., Karataeva O.V. Atrial fibrillation in the patients with obesity and arterial hypertension. The Russian Archives of Internal Medicine. 2015;(5):62-64. (In Russ.) https://doi.org/10.20514/2226-6704-2015-0-5-62-64